What is Simulations Plus?
Simulations Plus is a distinguished software and consulting firm specializing in advanced modeling and simulation solutions tailored for the pharmaceutical and biotechnology industries. Their sophisticated software tools are instrumental in predicting drug behavior within the human body, thereby accelerating drug discovery and development pipelines. The company's offerings encompass critical research areas such as absorption, distribution, metabolism, and excretion (ADME) modeling, alongside population pharmacokinetics and clinical trial simulations. Serving a global clientele that includes major pharmaceutical corporations, emerging biotechnology firms, academic institutions, and regulatory bodies, Simulations Plus empowers informed decision-making throughout the drug development lifecycle. Their reputation is built on pioneering computational modeling and a steadfast commitment to advancing pharmaceutical science through technological innovation.
How much funding has Simulations Plus raised?
Simulations Plus has raised a total of $5.8M across 1 funding round:
Stock Offering
$5.8M
Stock Issuance/Offering (1997): $5.8M, investors not publicly disclosed
What's next for Simulations Plus?
The substantial enterprise-level funding and recent strategic investment signal a phase of accelerated growth and market expansion for Simulations Plus. This capital infusion is likely to fuel further development of their advanced simulation software, potentially leading to new product lines or enhancements to existing platforms. Strategic investments often indicate a focus on market penetration, acquisitions, or strengthening competitive advantages. Given the company's mature lifecycle stage, future initiatives may involve expanding their service offerings, forging new strategic partnerships, or enhancing their global reach to capture a larger share of the burgeoning biopharmaceutical R&D market. Continued innovation in computational modeling will be key to maintaining their leadership position.
See full Simulations Plus company page
